NBIX
NEUROCRINE BIOSCIENCES INC
NEUROCRINE BIOSCIENCES INC (NBIX) has 25 SEC Form 4 filings (90 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 13, 2026.
The most active filer is Chief Regulatory Officer Delaet Ingrid with 4 filings. Insiders have net sold $52.9M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Kyle W. Gano
- Employees:1,800
- HQ:San Diego, CA, US
- IPO:1996-05-23
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$52.9M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$17.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Regulatory Officer | Sale | 4,367 | $791K | Jul 13 | SEC ↗ | |
| Chief Legal Officer | Sale | 10,000 | $1.8M | Jul 13 | SEC ↗ | |
Delaet IngridFirst filing | Chief Regulatory Officer | Sale | 3,401 | $607K | Jul 9 | SEC ↗ |
Delaet IngridFirst filing | Chief Regulatory Officer | Sale | 2,737 | $489K | Jul 9 | SEC ↗ |
Delaet IngridFirst filing | Chief Regulatory Officer | Sale | 8,433 | $1.5M | Jul 9 | SEC ↗ |
Lippoldt DarinFirst filing | Chief Legal Officer | Sale | 200 | $34K | Jun 30 | SEC ↗ |
Lippoldt DarinFirst filing | Chief Legal Officer | Sale | 9,800 | $1.7M | Jun 30 | SEC ↗ |
SHERWIN STEPHEN AFirst filing | Director | Sale | 25,000 | $4.1M | Jun 9 | SEC ↗ |
Onyia JudeFirst filing | Chief Scientific Officer | Sale | 11,000 | $1.7M | May 29 | SEC ↗ |
GORMAN KEVIN CHARLESFirst filing | Director | Sale | 245,088 | $37.8M | May 21 | SEC ↗ |
POPS RICHARD FFirst filing | Director | Sale | 15,000 | $2.4M | May 18 | SEC ↗ |
Related companies
NEUROCRINE BIOSCIENCES INC is in the Healthcare sector.